A mouse model with features of familial combined hyperlipidemia

Science

Volumn 275, Issue 5298, 1997, Pages 391-394

  Masucci Magoulas, Lori ^a   Goldberg, Ira J ^a   Bisgaier, Charles L ^a   Serajuddin, Humaira ^a   Francone, Omar L ^a   Breslow, Jan L ^a   Tall, Alan R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIETARY INTAKE; FAMILIAL HYPERLIPEMIA; GENETIC PREDISPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIET; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; GLYCOPROTEINS; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERLIPOPROTEINEMIA TYPE IV; LIPOPROTEINS; LIPOPROTEINS, VLDL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, LDL; TRANSGENES; TRIGLYCERIDES;

EID: 0031035182     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.275.5298.391     Document Type: Article

References (36)

1. J. L. Goldstein, H. G. Schrott, W. R. Hazzard, E. L. Bierman, A. G. Motulsky, J. Clin. Invest. 52, 1544 (1973).
2. J. D. Brunzell et al., J. Lipid Res. 24, 147 (1983).
3. P. Cullen, B. Farren, J. Scott, M. Farrall, Arterioscler. Thromb. 14, 1233 (1994).
4. A. P. Wojciechowski et al., Nature 349, 161 (1991). The genes for apolipoproteins A-I, C-III, and A-IV form a cluster on chromosome 11 [G. A. Bruns, S. K. Karathanasis, J. L. Breslow, Arteriosclerosis 4, 97 (1984)]. These genes encode apoproteins involved in the formation and metabolism of VLDL and HDL.
5. A. P. Wojciechowski et al., Nature 349, 161 (1991). The genes for apolipoproteins A-I, C-III, and A-IV form a cluster on chromosome 11 [G. A. Bruns, S. K. Karathanasis, J. L. Breslow, Arteriosclerosis 4, 97 (1984)]. These genes encode apoproteins involved in the formation and metabolism of VLDL and HDL.
6. C.-F. Xu et al., Clin. Genet. 46, 385 (1994).
7. S. P. Babirak et al., Arterioscler. Thromb. 12, 1176 (1992).
8. Y. Ito, N. Azrolan, A. O'Connell, A. Walsh, J. L. Breslow, Science 249, 790 (1990); K. Aalto-Setälä et al., J. Clin. Invest. 90, 1889 (1992).
9. Y. Ito, N. Azrolan, A. O'Connell, A. Walsh, J. L. Breslow, Science 249, 790 (1990); K. Aalto-Setälä et al., J. Clin. Invest. 90, 1889 (1992).
10. S. Ishibashi et al., J. Clin. Invest. 92, 833 (1994).
11. M. J. Callow, L. J. Stoltzfus, R. M. Lawn, E. M. Rubin, Proc. Natl. Acad. Sci. U.S.A. 91, 2130 (1994); G. Chiesa et al., J. Clin. Invest. 32, 23747 (1993).
12. M. J. Callow, L. J. Stoltzfus, R. M. Lawn, E. M. Rubin, Proc. Natl. Acad. Sci. U.S.A. 91, 2130 (1994); G. Chiesa et al., J. Clin. Invest. 32, 23747 (1993).
13. L. B. Agellon et al., J. Biol. Chem. 266, 10796 (1991); X.-C. Jiang, L. B. Agellon, A. Walsh, J. L. Breslow, A. R. Tall, J. Clin. Invest. 90, 1290 (1992).
14. L. B. Agellon et al., J. Biol. Chem. 266, 10796 (1991); X.-C. Jiang, L. B. Agellon, A. Walsh, J. L. Breslow, A. R. Tall, J. Clin. Invest. 90, 1290 (1992).
15. Analysis of the plasma lipoprotein triglyceride distribution by gel filtration chromatography showed an increase in IDL-LDL triglyceride (858 mg/dl) and HDL triglyceride (57 mg/dl) in LDLR0/C3/CETP mice compared with IDL-LDL triglyceride (350 mg/dl) and HDL triglyceride (10 mg/dl) in LDLR0/C3 mice.
16. J. M. Dietschy, S. D. Turley, D. K. Spady, J. Lipid Res. 34, 1637 (1993).
17. S. Venkatesan, P. Cullen, P. Pacy, D. Halliday, J. Scott, Arterioscler. Thromb. 13, 1110 (1993); J. D. Brunzell, A. D. Sniderman, J. J. Albers, P. O. Kwiterovich Jr., Arteriosclerosis 4, 79 (1984).
18. S. Venkatesan, P. Cullen, P. Pacy, D. Halliday, J. Scott, Arterioscler. Thromb. 13, 1110 (1993); J. D. Brunzell, A. D. Sniderman, J. J. Albers, P. O. Kwiterovich Jr., Arteriosclerosis 4, 79 (1984).
19. T. Hayek et al., J. Clin. Invest. 96, 2071 (1995).
20. C. J. Fielding and P. E. Fielding, J. Lipid Res. 36, 211 (1995).
21. M. Dammerman, L. A. Sandkuijl, J. L. Halaas, W. Chung, J. L. Breslow, Proc. Natl. Acad. Sci. U.S.A. 90, 4562 (1993); Q. Zeng et al., Hum. Genet. 95, 371 (1994).
22. M. Dammerman, L. A. Sandkuijl, J. L. Halaas, W. Chung, J. L. Breslow, Proc. Natl. Acad. Sci. U.S.A. 90, 4562 (1993); Q. Zeng et al., Hum. Genet. 95, 371 (1994).
23. M. R. Hayden et al., Am. J. Hum. Genet. 40, 421 (1987).
24. G. M. Dallinga-Thie et al., J. Lipid Res. 37, 136 (1996).
25. W. W. Li et al., J. Clin. Invest. 96, 2601 (1995).
26. B. Staels et al., ibid. 95, 705 (1995); S. Haubenwallner et al., J. Lipid Res. 36, 2541 (1995).
27. B. Staels et al., ibid. 95, 705 (1995); S. Haubenwallner et al., J. Lipid Res. 36, 2541 (1995).
28. S. M. Grundy, A. Chait, J. D. Brunzell, Arteriosclerosis 7, 203 (1987).
29. K. Aalto-Setälä et al., J. Lipid Res. 37, 1802 (1996).
30. Z.-S. Ji, S. Fazio, Y.-L. Lee, R. W. Mahley, J. Biol. Chem. 269, 2764 (1994).
31. N. S. Schacter et al., J. Clin. Invest. 98, 846 (1996).
32. W.-S. Yang, D. N. Nevin, R. Peng, J. D. Brunzell, S. S. Deeb, Proc. Natl. Acad. Sci. U.S.A. 92, 4462 (1995); E. Gagne, J. Genest Jr., H. Zhang, L. A. Clarke, M. R. Hayden, Arterioscler. Thromb. 14, 1250 (1994).
33. W.-S. Yang, D. N. Nevin, R. Peng, J. D. Brunzell, S. S. Deeb, Proc. Natl. Acad. Sci. U.S.A. 92, 4462 (1995); E. Gagne, J. Genest Jr., H. Zhang, L. A. Clarke, M. R. Hayden, Arterioscler. Thromb. 14, 1250 (1994).
34. K. A. Kieft, T. M. A. Bocan, B. R. Krause, J. Lipid Res. 32, 859 (1991). Diluted samples of pooled plasma from groups of five or six mice were analyzed by using Superose 6 HR column chromatography to fractionate the lipoproteins. Total cholesterol and triglyceride concentrations were determined by enzymatic assay on total plasma or lipoprotein fractions. Separated lipoproteins in the column eluant were quantified by an online column enzymatic assay for cholesterol or by enzymatic assay of individual fractions. All cholesterol profiles are normalized to represent a constant amount of plasma injected.
35. E. M. Rubin, R. M. Krauss, E. A. Spangler, J. G. Verstuyft, S. M. Clift, Nature 353, 265 (1991).
36. We thank L. Royer for help in quantifying APOA1 in α-HDL and pre-β-HDL. APOB transgenic mice were provided by E. R. Rubin. Supported by NIH grants HL 54591 and HL 21006.